The high adoption of technological advancement is one of the major driving factors for the growth of the global electrophysiology catheters market. Electrophysiology technology is advancing at a rapid pace along with the new ablation methods to enhance atrial fibrillation treatments, miniaturized diagnostic system and new implantable rhythm management devices which reduce procedure with less invasive. The technological development has prompted the introduction of new devices and products in the electrophysiology catheters market are expected to grow during the forecast period. For instance, in March 2017, Abbott Laboratories Inc. declared the US FDA approval for FlexAbility ablation catheter, sensor-enabled to increase the accuracy and versatility during cardiac ablation procedures and for the treatment of atrial flutter. Due to this approval, Abbott has widened its portfolio related to electrophysiology to effectively treat patients suffering from cardiac arrhythmias and supports physicians to solve complex cases.

Increasing demand of diagnostic catheters for early diseases diagnosis boost the market growth

The increasing demand for diagnostic catheters are one of the major driving factors that are fueling the growth of the electrophysiology catheters market. The prognosis of patients along with adult congenital heart diseases has enhanced significantly owing to early diagnosis and enhancement in surgical corrective techniques. ERG test is an effective method in observing the patient for early treatment. VEP can reveal early functional changes in amplitude which are undetectable through different other means.  The technology can confirm a diagnosis that provides a practitioner to start treatment much earlier. VEP test is useful in determining asymmetry and early indicator of a number of conditions. Additionally, corneal hysteresis is not clear in one eye than full analysis with VEP test may discover changes in latency.

Moreover, the catheter is utilized to deliver low voltage and high-frequency current which destroy the heart tissue that is responsible for the arrhythmia. The patients who have done with the treatment of catheter ablation has experience of long term reduction in the number of arrhythmias and return to normal heart rhythm. The technology Carto 3 has provided three-dimensional views of the patient’s heart that enables the electrophysiologist to identify the origin of abnormal rhythm accurately and provide radio frequency catheter ablation with large rate.  The different benefit of cardiac ablation therapy includes better quality of care, cost-effective and better quality of life. Thus, early treatment and diagnosis for catheters ablation are fueling the growth of the market.

In the economies of Asia-Pacific region, the healthcare systems are facing challenges such as the burden of increasing and aging population, delivery of adequate healthcare facility and low per capita income. The healthcare expenditure in these countries is growing significantly with the increasing interest from both private and public sectors. Economies of Asia-Pacific region such as China and India are amongst the fastest developing countries in the adoption and implementation of new technologies across the globe. Increasing diagnostic rate of diseases and increasing healthcare expenditure in these countries are anticipated to lead to increased demand for electrophysiology catheters during the forecast period.

To Request a Sample of our Report on Electrophysiology catheters Market:https://www.omrglobal.com/request-sample/electrophysiology-catheters-market

Electrophysiology catheters Market Segmentation

By Product Type

  • Diagnostic Catheters
  • Ablation Catheters
  • Smart home display

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

A full report of Electrophysiology Catheters Market is available at: https://www.omrglobal.com/industry-reports/electrophysiology-catheters-market

Electrophysiology Catheters Market– Segment by Region

North America          

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia-Pacific   

  • China
  • Japan
  • India
  • Rest of Asia-Pacific

Rest of the World

  • Middle East & Africa
  • Latin America

Company Profiles

  • Abbott Laboratories
  • ADInstruments Pty Ltd.
  • Biomerics, LLC
  • Biotronik, Inc.
  • Boston Scientific Corp.
  • CathRx Ltd.
  • EPIMED International, Inc.
  • Integer holdings corp.
  • Johnson & Johnson Services, Inc.
  • Japan Lifeline Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.

Reasons to Buy From us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments (0)
No login
Login or register to post your comment